Balchem Corp
A maker of encapsulated nutrients and specialty ingredients for food, animal feed, and health products. Its brands include Balchem Encapsulates, which protect sensitive ingredients like choline and vitamins so they survive processing and release at the right moment, used by bakers, dairy makers, and animal nutrition companies. Founded in 1967 in New York, the company's name blends "balanced chemistry," reflecting its focus on precisely delivering nutrients. One fun fact: its encapsulation technology is used in products ranging from breakfast cereals to cattle feed supplements.
Granted 25.6K
Granted 8.3K
Granted 3.1K
Granted 7.8K · Sold 6.0K
Granted 3.3K · Sold 1.2K
Granted 5.1K
Granted 4.0K
Granted 6.9K · Sold 8.0K
Granted 870
Granted 2.2K
Granted 870
Granted 870
Granted 3.2K
Granted 870
Granted 870
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Harris Theodore LChairman, President & CEO, Director · 5 transactions | — | 94.4K | 25.6K | — | — |
| Bengtsson Carl MartinEVP & Chief Financial Officer · 5 transactions | +20.2% | 29.0K | 8.3K | — | — |
| Tignor Michael BrentSVP & Chief HR Officer · 5 transactions | +16.8% | 12.2K | 3.1K | — | — |
| van Gunsteren Job LeonardSVP and GM, Specialty Products · 8 transactions | -2.5% | 10.1K | 7.8K | — | 6.0K |
| Reid Martin LutherSVP Chief Supply Chain Officer · 6 transactions | -5.8% | 9.6K | 3.3K | — | 1.2K |
| Boned FredericSVP/GM, Human Nutri. & Health · 6 transactions | +33.8% | 9.4K | 5.1K | — | — |
| Miyata HatsukiEVP, CLO, & Secretary · 5 transactions | +38.8% | 9.2K | 4.0K | — | — |
| Fischer David BDirector · 5 transactions | -11.3% | 8.9K | 6.9K | — | 8.0K |
| Wineinger Matthew DavidDirector · 1 transaction | +12.2% | 8.0K | 870 | — | — |
| Backus William A.VP & Chief Accounting Officer · 5 transactions | +16.8% | 7.0K | 2.2K | — | — |
| Knutson Daniel EDirector · 1 transaction | +14.4% | 6.9K | 870 | — | — |
| Fish Kathleen BDirector · 1 transaction | +34% | 3.4K | 870 | — | — |
| Graham GeorgeSVP and Chief R&D Officer · 2 transactions | — | 3.2K | 3.2K | — | — |
| Rigaud OlivierDirector · 1 transaction | +57.2% | 2.4K | 870 | — | — |
| Vicente MonicaDirector · 1 transaction | +57.2% | 2.4K | 870 | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -15.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.